Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Clinical and metabolic studies in type III hyperlipoproteinemia

Stuyt, P.M.J.

Publication date

January 1982

Publisher

[S.l. : s.n.]

Abstract

Contains fulltext : mmubn000001_026974789.pdf (publisher's version ) (Open Access)Promotor : A. van ’t Laar167 p

Extracted data

Topics

Related items

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

Chan, D.
Chen, Meifania
Ooi, E.
Watts, G.

January 2008

Background: Hypertriglyceridaemia, commonly found in subjects with obesity and type 2 diabetes melli...

CLINICAL STUDY c h

February 2015

rs it d g an ve sm glycoprotein IIIa Leu33Pro, apolipoprotein E2/E3/E4, methylenetetrahydrofolate re...

Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low-density lipoprotein heterogeneity

Bredie, S.J.H.
Demacker, P.N.M.
Stalenhoef, A.F.H.

January 1997

Contains fulltext : 24395___.PDF (publisher's version ) (Open Access

Hyperlipoproteinemia: a study on diagnostic methods

Demacker, P.N.M.

January 1978

Contains fulltext : mmubn000001_025234641.pdf (publisher's version ) (Open Access)...

Metabolic studies in various forms of hypertriglyceridemia in man

Stalenhoef, A.F.H.

January 1982

Contains fulltext : mmubn000001_027014339.pdf (publisher's version ) (Open Access)...

The spectrum of type III hyperlipoproteinemia

Sniderman, A.D.
Graaf, J. de
Thanassoulis, G.
Tremblay, A.J.
Martin, S.S.
Couture, P.

January 2018

Item does not contain fulltextBACKGROUND: Type III hyperlipoproteinemia is a highly atherogenic dysl...

Myelomatosis with type III hyperlipoproteinemia - clinical and metabolic studies

Cortese, Claudio
Lewis, Barry
Miller, Norman E.
Peyman, Michael A.
Rao, Suresh N.
Slavin, Brenda
Sule, Usha
Turner, Peter R.
Utermann, Gerd
Wing, Anthony J.
Weight, Michael
Wootton, Richard

July 1982

We investigated the metabolism of intermediate-density lipoproteins (IDL [1.006 to 1.019 g per milli...

TYPE III HYPERLIPOPROTEINEMIA

Lovis Rosati
Edward R. Napier
Ph. D
Joihn G. Batsakis

October 2016

CELLULOSE ACETATE AS THE ELECTROPHORETIC SUPPORT hlEDIUh1 for the separa-tion of serum lipoproteins,...

Berlin · New York

Apolipoprotein E To B Ratio
A Marker
Type Iii Hyperlipoproteinaemia
W. M Rz
G. Feussner
R. Siekmeier
Bettina Donnerhak
L. Schaaf
V. Ruzicka
W. Gro

January 1992

Summary: Apolipoproteins B and E were determined in 40 patients with type III hyperlipoproteinaemia ...

Expression of type III hyperlipoproteinemia in apolipoprotein E2 (Arg158 --> Cys) homozygotes is associated with hyperinsulinemia

Stalenhoef, A.F.
Hoogerbrugge, Nicoline
Kastelein, John
Gevers Leuven, J.A.
Duijn, Cornelia
Havekes, L.M.
Smelt, A.H.
Beer, Femke

January 2002

Type III hyperlipoproteinemia (HLP) is mainly found in homozygous carriers of apolipoprotein E2 (apo...

Familial combined hyperlipidemia: metabolic and genetic aspects

Bredie, S.J.H.

January 1997

Contains fulltext : mmubn000001_255044194.pdf (publisher's version ) (Open Access)...

De medicamenteuze behandeling van type II hyperlipoproteinemie: een prospectieve studie

Schade, R.W.B.

January 1976

Contains fulltext : mmubn000001_235213101.pdf (publisher's version ) (Open Access)...

The expression of type III hyperlipoproteinemia: involvement of lipolysis genes

Henneman, Peter
de Beer, F
Moghaddam, PH
Huijts, P
Stalenhoef, AFH
Kastelein, JJP
Duijn, Cornelia
Havekes, LM
Frants, RR
van Dijk, KW
Smelt, AHM

January 2009

Type III hyperlipoproteinemia (HLP) is mainly found in homozygous apolipoprotein (APO) E2 (R158C) ca...

The expression of type III hyperlipoproteinemia: Involvement of lipolysis genes

Henneman, P.
Sman-de Beer, F. van der
Moghaddam, P.H.
Huijts, P.
Stalenhoef, A.F.H.
Kastelein, J.J.P.
Duijn, C.M. van
Havekes, L.M.
Frants, R.R.
Dijk, K.W. van
Smelt, A.H.M.

January 2009

Type III hyperlipoproteinemia (HLP) is mainly found in homozygous apolipoprotein (APO) E2 (R158C) ca...

Type III Hyperlipoproteinemia: An Analysis of Two Contemporary Definitions

Donald S. Fredrickson
Joel Morganroth
Robert I. Levy

October 2016

Two current definitions of type III hyperlipoproteinemia, "floating beta " lipoproteins an...

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

Chan, D.
Chen, Meifania
Ooi, E.
Watts, G.

January 2008

Background: Hypertriglyceridaemia, commonly found in subjects with obesity and type 2 diabetes melli...

CLINICAL STUDY c h

February 2015

rs it d g an ve sm glycoprotein IIIa Leu33Pro, apolipoprotein E2/E3/E4, methylenetetrahydrofolate re...

Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low-density lipoprotein heterogeneity

Bredie, S.J.H.
Demacker, P.N.M.
Stalenhoef, A.F.H.

January 1997

Contains fulltext : 24395___.PDF (publisher's version ) (Open Access

Hyperlipoproteinemia: a study on diagnostic methods

Demacker, P.N.M.

January 1978

Contains fulltext : mmubn000001_025234641.pdf (publisher's version ) (Open Access)...

Metabolic studies in various forms of hypertriglyceridemia in man

Stalenhoef, A.F.H.

January 1982

Contains fulltext : mmubn000001_027014339.pdf (publisher's version ) (Open Access)...

The spectrum of type III hyperlipoproteinemia

Sniderman, A.D.
Graaf, J. de
Thanassoulis, G.
Tremblay, A.J.
Martin, S.S.
Couture, P.

January 2018

Item does not contain fulltextBACKGROUND: Type III hyperlipoproteinemia is a highly atherogenic dysl...

Myelomatosis with type III hyperlipoproteinemia - clinical and metabolic studies

Cortese, Claudio
Lewis, Barry
Miller, Norman E.
Peyman, Michael A.
Rao, Suresh N.
Slavin, Brenda
Sule, Usha
Turner, Peter R.
Utermann, Gerd
Wing, Anthony J.
Weight, Michael
Wootton, Richard

July 1982

We investigated the metabolism of intermediate-density lipoproteins (IDL [1.006 to 1.019 g per milli...

TYPE III HYPERLIPOPROTEINEMIA

Lovis Rosati
Edward R. Napier
Ph. D
Joihn G. Batsakis

October 2016

CELLULOSE ACETATE AS THE ELECTROPHORETIC SUPPORT hlEDIUh1 for the separa-tion of serum lipoproteins,...

Berlin · New York

Apolipoprotein E To B Ratio
A Marker
Type Iii Hyperlipoproteinaemia
W. M Rz
G. Feussner
R. Siekmeier
Bettina Donnerhak
L. Schaaf
V. Ruzicka
W. Gro

January 1992

Summary: Apolipoproteins B and E were determined in 40 patients with type III hyperlipoproteinaemia ...

Expression of type III hyperlipoproteinemia in apolipoprotein E2 (Arg158 --> Cys) homozygotes is associated with hyperinsulinemia

Stalenhoef, A.F.
Hoogerbrugge, Nicoline
Kastelein, John
Gevers Leuven, J.A.
Duijn, Cornelia
Havekes, L.M.
Smelt, A.H.
Beer, Femke

January 2002

Type III hyperlipoproteinemia (HLP) is mainly found in homozygous carriers of apolipoprotein E2 (apo...

Familial combined hyperlipidemia: metabolic and genetic aspects

Bredie, S.J.H.

January 1997

Contains fulltext : mmubn000001_255044194.pdf (publisher's version ) (Open Access)...

De medicamenteuze behandeling van type II hyperlipoproteinemie: een prospectieve studie

Schade, R.W.B.

January 1976

Contains fulltext : mmubn000001_235213101.pdf (publisher's version ) (Open Access)...

The expression of type III hyperlipoproteinemia: involvement of lipolysis genes

Henneman, Peter
de Beer, F
Moghaddam, PH
Huijts, P
Stalenhoef, AFH
Kastelein, JJP
Duijn, Cornelia
Havekes, LM
Frants, RR
van Dijk, KW
Smelt, AHM

January 2009

Type III hyperlipoproteinemia (HLP) is mainly found in homozygous apolipoprotein (APO) E2 (R158C) ca...

The expression of type III hyperlipoproteinemia: Involvement of lipolysis genes

Henneman, P.
Sman-de Beer, F. van der
Moghaddam, P.H.
Huijts, P.
Stalenhoef, A.F.H.
Kastelein, J.J.P.
Duijn, C.M. van
Havekes, L.M.
Frants, R.R.
Dijk, K.W. van
Smelt, A.H.M.

January 2009

Type III hyperlipoproteinemia (HLP) is mainly found in homozygous apolipoprotein (APO) E2 (R158C) ca...

Type III Hyperlipoproteinemia: An Analysis of Two Contemporary Definitions

Donald S. Fredrickson
Joel Morganroth
Robert I. Levy

October 2016

Two current definitions of type III hyperlipoproteinemia, "floating beta " lipoproteins an...

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

Chan, D.
Chen, Meifania
Ooi, E.
Watts, G.

January 2008

Background: Hypertriglyceridaemia, commonly found in subjects with obesity and type 2 diabetes melli...

CLINICAL STUDY c h

February 2015

rs it d g an ve sm glycoprotein IIIa Leu33Pro, apolipoprotein E2/E3/E4, methylenetetrahydrofolate re...

Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low-density lipoprotein heterogeneity

Bredie, S.J.H.
Demacker, P.N.M.
Stalenhoef, A.F.H.

January 1997

Contains fulltext : 24395___.PDF (publisher's version ) (Open Access